» Articles » PMID: 27557950

Neonatal Domoic Acid Alters in Vivo Binding of [C]yohimbine to α-adrenoceptors in Adult Rat Brain

Overview
Specialty Pharmacology
Date 2016 Aug 26
PMID 27557950
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: Epilepsy is a debilitating seizure disorder that affects approximately 50 million people. Noradrenaline reduces neuronal excitability, has anticonvulsant effects and is protective against seizure onset.

Objective: We investigated the role of α-adrenoceptors in vivo in a neonatal domoic acid (DOM) rat model of epilepsy.

Methods: We injected male Sprague-Dawley rats daily from postnatal day 8-14 with saline or one of two sub-convulsive doses, 20 μg/kg (DOM20) or 60 μg/kg (DOM60) DOM, an AMPA/kainate receptor agonist. The rats were observed in open field, social interaction and forced swim tests at day 50, 75 and 98, respectively. At ~120 days of age, four rats per group were injected and scanned with [C]yohimbine, an α-adrenoceptor antagonist, and scanned in a Mediso micro positron emission tomography (PET) scanner to measure αadrenoceptor binding.

Results: DOM60-treated rats spent more time in the periphery during the open field test and had a significant 26-33 % reduction in [C]yohimbine binding in the hypothalamus, hippocampus and orbital prefrontal cortex compared to saline-treated rats. On the other hand, DOM20 rats had a significant 34-40 % increase in [C]yohimbine binding in the hypothalamus, amygdala and entorhinal cortex compared to saline-treated rats, with no obvious behavioural differences.

Conclusions: The current data clearly indicate that low concentrations of DOM given to rats in their second week of life induces long-term changes in α-adrenoceptor binding in rat brain that may have relevance to the progression of an epilepsy phenotype.

Citing Articles

Life Course Considerations in Environmental Health: Developmental Neurotoxicity of Domoic Acid at Doses Below Acute Effect Levels in Adult Humans.

Campbell M, Murphy S, Klasing S, Niknam Y, Iyer P, Stanton B Birth Defects Res. 2024; 116(12):e2419.

PMID: 39670542 PMC: 11639046. DOI: 10.1002/bdr2.2419.


Public health risks associated with chronic, low-level domoic acid exposure: A review of the evidence.

Petroff R, Hendrix A, Shum S, Grant K, Lefebvre K, Burbacher T Pharmacol Ther. 2021; 227:107865.

PMID: 33930455 PMC: 8939048. DOI: 10.1016/j.pharmthera.2021.107865.


In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET.

Thomsen M, Jacobsen J, Lillethorup T, Schacht A, Simonsen M, Romero-Ramos M J Cereb Blood Flow Metab. 2020; 41(4):819-830.

PMID: 32538280 PMC: 7983510. DOI: 10.1177/0271678X20931140.


Radioligand binding analysis of α adrenoceptors with [C]yohimbine in brain in vivo: Extended Inhibition Plot correction for plasma protein binding.

Phan J, Landau A, Jakobsen S, Wong D, Gjedde A Sci Rep. 2017; 7(1):15979.

PMID: 29167492 PMC: 5700124. DOI: 10.1038/s41598-017-16020-1.

References
1.
Starke K, Gothert M, Kilbinger H . Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev. 1989; 69(3):864-989. DOI: 10.1152/physrev.1989.69.3.864. View

2.
Marriott A, Tasker R, Ryan C, Doucette T . Neonatal domoic acid abolishes latent inhibition in male but not female rats and has differential interactions with social isolation. Neurosci Lett. 2014; 578:22-6. DOI: 10.1016/j.neulet.2014.06.025. View

3.
Bernard P, MacDonald D, Gill D, Ryan C, Tasker R . Hippocampal mossy fiber sprouting and elevated trkB receptor expression following systemic administration of low dose domoic acid during neonatal development. Hippocampus. 2007; 17(11):1121-33. DOI: 10.1002/hipo.20342. View

4.
Ryan C, Robbins M, Smith M, Gallant I, Adams-Marriott A, Doucette T . Altered social interaction in adult rats following neonatal treatment with domoic acid. Physiol Behav. 2010; 102(3-4):291-5. DOI: 10.1016/j.physbeh.2010.11.020. View

5.
Raedt R, Clinckers R, Mollet L, Vonck K, El Tahry R, Wyckhuys T . Increased hippocampal noradrenaline is a biomarker for efficacy of vagus nerve stimulation in a limbic seizure model. J Neurochem. 2011; 117(3):461-9. DOI: 10.1111/j.1471-4159.2011.07214.x. View